IQWiG-Autumn-Symposiums from 2005 to 2013
Every year health experts from Germany and abroad meet in Cologne at the IQWiG Autumn Symposium to discuss current issues of the healthcare system. An overview of the topics and presentations from 2005 to 2013 is shown below.
IQWiG Autumn Symposium 2013
Quality of life in health care: Do we know what we are doing?
In the competing fields of patients' interests, legislation and research, the content of the term "quality of life" is interpreted differently, depending on the perspective. "Quality of life in health care: Do we know what we are doing?" – this is what we asked experts from research, medical practice and self-government, as well as patient representatives and other participants at the Autumn Symposium held in Cologne on 29 and 30 November 2013.
IQWiG Autumn Symposium 2012
Cancer: Is everything different? / Can less be more?
Current aspects in medicine and health care were discussed again in Cologne on 23rd and 24th November 2012. This year the speakers at the IQWiG Autumn Symposium posed two controversially discussed questions in health care: "Cancer: Is everything different?” and "Can less be more?”
IQWiG Autumn Symposium 2011
Methodology: between regulations and arbitrariness / Personal responsibility
Current and controversial aspects in medicine and health policy was discussed again in Cologne on 25-26 November 2011. This year the IQWiG Autumn Symposium, which has been taken place for the seventh time, was address the topics "Methodology: between regulations and arbitrariness” and "Personal responsibility”.
IQWiG Autumn Symposium 2010
Balancing of benefits and harms in health system decision-making / Data transparency as a precondition to the informed balancing of benefits and harms
How can the benefits and harms of interventions in different medical areas be balanced against each other? How evidence-based can such a balancing be? How do the approaches to such a balancing of benefits and harms differ from the perspective of the German Drug Law on the one hand and that of the Social Code Book on the other? Which study data are required to be able to actually perform an informed balancing of benefits and harms? For example, how is the development of clinical practice guidelines affected if only part of the study data is available? What about data transparency in the field of medical devices? Leading health care researchers will discuss these and other questions at IQWiG's annual Autumn Symposium in Cologne on 19 and 20 November.
IQWiG Autumn Symposium 2009
Medicine - belief and knowledge / Health care system - experiencing and funding it
What value judgements are made in medical science? How many medical decisions are based on scientific proof, on proven knowledge? Can the pharmaceutical industry carry out objective research? Can we justify any rationing of health resources? What reforms are necessary to improve health care?
IQWiG Autumn Symposium 2008
Assessment of the Benefits and Harms of Medical Interventions / Science, Society, and the Individual
Leading health care experts from home and abroad met again at the IQWiG Autumn Symposium in Cologne on 28 and 29 November to discuss current and controversial aspects of medicine.
The first day focused on a key topic of the Institute: evaluating the benefit and harm of medical interventions. The topic for the second day of the symposium explored the requirements of and consequences for stakeholders in health care on the one hand, and insured citizens and patients on the other, as a result of the scientific knowledge obtained.
IQWiG Autumn Symposium 2007
Knowledge as the basis of physicians' and patients' decision-making / The financial significance of disease and health
Can therapy outcomes be improved if patients are well informed? Which legal aspects need to be considered when informing patients? Why are many drugs so expensive? How are prices for medical services calculated and determined in other countries? Leading health care experts pursued these and other questions in Cologne on 23 and 24 November.
IQWiG Autumn Symposium 2006
Hopes and Errors in Medicine / Costs, Quality and Justice in the Health Care System
About 250 health care experts from Germany and abroad met in Cologne to discuss health care issues. What is the state of quality improvement in the pharmaceutical industry and quality control in medicine? Is the truth bearable? What are the benefits and harms of information for terminally ill patients?
IQWiG Autumn Symposium 2005
Diagnosis, Screening and Patient Oriented Research / Insight and Decision in Medicine
In spring 2005, IQWiG decided to host its own symposium once a year in order to enable a direct exchange of ideas regarding new or controversial issues in evidence-based medicine and to involve a broader professional public in Germany. The results of the discussions will be incorporated in the IQWiG methods and will thus have an impact on how studies will be evaluated in the future. The first event of this type, the IQWiG Autumn Symposium 2005, was held on the 18th and 19th of November in Cologne.
Together with IQWiG
employees, about 170 national and international health scientists discussed
selected aspects of medicine. Epidemiologists and statisticians were
represented as well as specialists from other medical fields. The presenters
were largely members of IQWiG’s Scientific Advisory Board, who before the
beginning of the symposium held a Board meeting in Cologne for the first time.
Meeting Programme (German Version)